Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach
Adv Ther
.
2022 Feb;39(2):909.
doi: 10.1007/s12325-021-02032-x.
Authors
Marjanne A Piena
1
,
Sonja Kroep
1
,
Claire Simons
2
,
Elisabeth Fenwick
3
,
Gerard T Harty
4
,
Schiffon L Wong
5
,
Ben A van Hout
6
Affiliations
1
MMA, Evidence & Access, OPEN Health, Rotterdam, Netherlands.
2
MMA, Evidence & Access, OPEN Health, York, UK.
3
MMA, Evidence & Access, OPEN Health, Oxford, UK.
4
The Healthcare Business of Merck KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany. Gerard.Harty@merckgroup.com.
5
EMD Serono, Billerica, MA, USA.
6
School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
PMID:
34997918
PMCID:
PMC9172692
DOI:
10.1007/s12325-021-02032-x
No abstract available
Publication types
Published Erratum